Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 14/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | USP2 | O75604 | 4/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL807944 | 0.93 | MEN1 (0.38) | ALDH1A1MAPTCYP3A4USP2SMN1; SMN2 | |
| SCHEMBL808315 | 0.87 | SMN1; SMN2 (0.39) | CYP1A2CYP2C19CYP2C9TSHRSMN1; SMN2 | |
| SCHEMBL808319 | 0.83 | NPC1 (0.43) | USP2SMN1; SMN2CYP2D6 | |
| SCHEMBL10287136 | 0.72 | ALDH1A1 (0.41) | ALDH1A1MAPTTSHRSMN1; SMN2 | |
| SCHEMBL795967 | 0.68 | NTRK1 (0.43) | ALDH1A1MAPTUSP2SMN1; SMN2POLB | |
| SCHEMBL419469 | 0.63 | RAB9A (0.68) | ALDH1A1MAPTCYP3A4CYP1A2CYP2C19 | |
| SCHEMBL807957 | 0.63 | LMNA (0.41) | ALDH1A1MAPTCYP3A4CYP1A2CYP2C19 | |
| SCHEMBL10287533 | 0.63 | ADRA2A (0.33) | ALDH1A1 | |
| SCHEMBL10287195 | 0.62 | MTOR (0.42) | MAPTTSHRSMN1; SMN2 | |
| SCHEMBL23035261 | 0.62 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP3A4USP2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012035023-A1 | TRIAZINE-OXADIAZOLES | NOVARTIS AG (CH) | 2012-03-22 | — | — | WO | disclosed |